Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

September 15, 2026; Volume 23,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Yang, Yanan

    1. Open Access
      Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer
      Xin Jin, Albert M. Li, Man Zhao, Haowen Jiang, Yiren Xiao, Michaela Yip, Stavros Melemenidis, Scott Jackson, Yanan Yang, Cathyrin Simmermaker, Meng-Ning Zhou, Subarna Sinha, Daniel J. Cuthbertson, Erinn B. Rankin and Jiangbin Ye
      Cancer Biology & Medicine September 2026, 23 (9) 1303-1319; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0444
  2. Ye, Jiangbin

    1. Open Access
      Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer
      Xin Jin, Albert M. Li, Man Zhao, Haowen Jiang, Yiren Xiao, Michaela Yip, Stavros Melemenidis, Scott Jackson, Yanan Yang, Cathyrin Simmermaker, Meng-Ning Zhou, Subarna Sinha, Daniel J. Cuthbertson, Erinn B. Rankin and Jiangbin Ye
      Cancer Biology & Medicine September 2026, 23 (9) 1303-1319; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0444
  3. Ye, Xuer

    1. Open Access
      Unravelling the role of PANoptosis in diseases: from emerging molecular mechanisms-to-therapeutic implications
      Yi Zhu, Shengming Ou, Xuer Ye, Juncheng Li, Xiaoya Nie, Hongwei Shao, Rongxin Zhang and Jinrong Zhu
      Cancer Biology & Medicine September 2026, 23 (9) 1230-1249; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0012
  4. Yip, Michaela

    1. Open Access
      Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer
      Xin Jin, Albert M. Li, Man Zhao, Haowen Jiang, Yiren Xiao, Michaela Yip, Stavros Melemenidis, Scott Jackson, Yanan Yang, Cathyrin Simmermaker, Meng-Ning Zhou, Subarna Sinha, Daniel J. Cuthbertson, Erinn B. Rankin and Jiangbin Ye
      Cancer Biology & Medicine September 2026, 23 (9) 1303-1319; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0444
  5. Yoshimura, Teizo

    1. Open Access
      SPRED2 suppresses the stemness of hepatocellular carcinoma through the p53/miR-506-3p/KLF4 pathway
      Tong Gao, Sachio Ito, Aye Moh-Moh-Aung, Tianyi Wang, Masayoshi Fujisawa, Toshiaki Ohara, Teizo Yoshimura and Akihiro Matsukawa
      Cancer Biology & Medicine September 2026, 23 (9) 1283-1302; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0247
  6. Yu, Haixia

    1. Open Access
      cGAS–STING pathway activation drives the cold-to-hot tumor transition and sensitizes immunotherapy
      Xinru Zhao, Shuai Meng, Hanzeng Cheng, Haixia Yu, Meiting Rong, Chao Zhang, Cien Qiu, Jie Zhang, Chunnuan Wu and Wenxia Zhao
      Cancer Biology & Medicine September 2026, 23 (9) 1250-1282; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0058
  7. Yu, Jun

    1. Open Access
      A foundation model-enhanced CT radiomics signature for the noninvasive assessment of tertiary lymphoid structures and prediction of therapy benefit in gastric cancer
      Xianchun Gao, Zhe Li, Jun Yu, Jiangpeng Wei, Didi Wen, Ning Han, Linbin Lu, Yongxi Song, Qiong Xiao, Guangtao Wu, Kun Feng, Shibo Wang, Zhongyang Zhang, Dai Zhang, Ling Chen, Zengshan Li, Minwen Zheng, Yong Xia and Yongzhan Nie
      Cancer Biology & Medicine September 2026, 23 (9) 1346-1351; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0076
  8. Yuan, Jiahuan

    1. Open Access
      FDX1 expression promotes DSF/Cu-induced cuproptosis in gastric cancer cells
      Qirong Li, Yi Guo, Jiahuan Yuan, Qiang Feng, Hengzong Zhou, Ming Hao, Boqiang Tao, Liqun Sun, Chao Lin, Jianfeng Mu, Gongliang Guo and Dongxu Wang
      Cancer Biology & Medicine September 2026, 23 (9) 1320-1340; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0323
Back to top
Previous

In this issue

Cancer Biology & Medicine: 23 (9)
Cancer Biology & Medicine
Vol. 23, Issue 9
15 Sep 2026
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire